Advertisement

Pharmaceutical & Diagnostic Innovation

, Volume 1, Issue 2, pp 28–30 | Cite as

Recent R&D Highlights

News & View
  • 6 Downloads

Among the more interesting presentations at the 18th International Diabetes Federation Congress held in Paris, France, in August 2003, were two focused on a needle-free delivery method for insulin and a new approach to the management of type 2 diabetes mellitus.

Breathe Easy – Inhaled Insulin is on the Way

The administration of insulin by inhalation offers advantages over injected insulin beyond the obvious benefit of needle-free delivery, according to studies presented at the meeting. In a phase III study, Exubera® (inhaled insulin) provided improved glycemic control and greater patient satisfaction, compared with Avandia® (rosiglitazone), while a second study showed that administration by inhalation provided more consistent exposure to insulin than SC delivery, resulting in more even control of plasma glucose levels.

Needle-free the way of the future

Speaking at a symposium entitled “Insulin: what have they done to you?”, Dr Lutz Heinemann from the Profil Institute for Metabolic...

Copyright information

© Adis Data Information BV 2003

Personalised recommendations